ArticleNature communications2026
Structural and functional dissection of a higher-order oligomerization interface in yeast ceramide synthase.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Ceramide synthases (CerSs) are crucial enzymes in sphingolipid metabolism and have shown therapeutic potential for treating various metabolic disorders. However, their regulatory mechanisms remain poorly understood. In this study, we report the cryo-electron microscopy structure of a yeast CerS (yCerS), composed of a catalytic Lac1 subunit and a regulatory Lip1 subunit, organized into a higher-order 4:4 assembly. This assembly is formed by dimerization of two 2:2 Lac1-Lip1 subcomplexes via an interface primarily involving the Lac1 subunit. Notably, within this interface, the C-terminal transmembrane helix (TM8) of Lac1 adopts a dramatically twisted conformation and engages in extensive interactions with TMs 6/7/8 of the adjacent Lac1 subunit. This structural rearrangement sterically occludes the catalytic chamber and blocks acyl-CoA substrate entry. Functional assays further demonstrate that, although structurally reminiscent of an autoinhibitory conformation, this interface is required for the regulation of ceramide output and cellular adaption during perturbation of complex sphingolipid biosynthesis. Together, our findings uncover a complex oligomerization-mediated regulatory mechanism in yCerS, advancing the mechanistic understanding of ceramide synthesis control and highlighting the nuanced role of oligomerization in modulating CerS activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.